What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 7.5% in the morning session after Barclays downgraded ...

We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...

On Monday, for the second time in as many business days, Illumina ( ILMN -4.11%) stock took it on the chin because of an analyst recommendation downgrade. The biotech's shares closed the day almost 6% ...

The Federal Trade Commission’s recent challenge to Microsoft’s acquisition of Activision has been rejected by a federal court ...

Shares of Illumina Inc. ILMN slipped 4.11% to $100.68 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.03% to 6,068.50 ...

China announced a wide range of measures on Tuesday targeting U.S. businesses including Google , farm equipment makers and ...

The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time ...

Illumina’s shares are somewhat volatile and ... Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy.

After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

And we truly believe that Illumina with our leading NDS technology and our innovation pipeline is -- will -- are serving and will continue to serve the Chinese customers and patients very ...

Shares of Illumina Inc. ILMN shed 5.47% to $104.99 Monday, on what proved to be an all-around favorable trading session for ...